Consistently, we also showed that activation of PAR-2 involved in the pathogenesis of allergic airway disorders was significantly elevated in patients with asthma and allergic rhinitis, and this activation was blunted by GB88 together with SBTI in PBMCs of patients with asthma and allergic rhinitis. This evidence concerns the gene F2RL1 and allergic rhinitis.